{"id":10633,"date":"2022-05-10T06:48:03","date_gmt":"2022-05-10T04:48:03","guid":{"rendered":"https:\/\/ggba.swiss\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/"},"modified":"2023-07-04T13:43:55","modified_gmt":"2023-07-04T11:43:55","slug":"la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/","title":{"rendered":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.asceneuron.com\/\" target=\"_blank\" rel=\"noopener\">Asceneuron<\/a> est une soci\u00e9t\u00e9 de phase clinique qui se consacre au ciblage des causes profondes des maladies neurod\u00e9g\u00e9n\u00e9ratives. Bas\u00e9e \u00e0 l&rsquo;<a href=\"https:\/\/epfl-innovationpark.ch\/\" target=\"_blank\" rel=\"noopener\">EPFL Innovation Park<\/a> \u00e0 Ecublens (canton de Vaud), la soci\u00e9t\u00e9 a annonc\u00e9 avoir re\u00e7u une deuxi\u00e8me bourse de la Michael J. Fox Foundation for Parkinson&rsquo;s Research (<a href=\"https:\/\/www.michaeljfox.org\/\" target=\"_blank\" rel=\"noopener\">MJFF<\/a>) pour acc\u00e9l\u00e9rer l&rsquo;\u00e9tude de son inhibiteur de O-GlcNAcase (OGA) ASN51 comme nouveau traitement potentiel de la maladie de Parkinson (PD).<\/p>\n<p>Aujourd&rsquo;hui, on estime que sept \u00e0 dix millions de personnes dans le monde sont atteintes de la MP. Bien qu&rsquo;il n&rsquo;existe actuellement aucun traitement curatif de la MP, Asceneuron se concentre sur le d\u00e9veloppement de th\u00e9rapeutiques par voie orale dont les besoins m\u00e9dicaux non satisfaits sont importants, y compris les tauopathies orphelines, la maladie d&rsquo;Alzheimer et la maladie de Parkinson.<\/p>\n<p>La bourse de la FFMJ financera une \u00e9tude pr\u00e9clinique de preuve de concept visant \u00e0 \u00e9valuer les propri\u00e9t\u00e9s modificatrices de la maladie de l&rsquo;inhibiteur de l&rsquo;O-GlcNAcase (OGA) ASN51 d&rsquo;Asceneuron dans un mod\u00e8le pr\u00e9clinique de la MP h\u00e9r\u00e9ditaire.<\/p>\n<h4>Des r\u00e9sultats sont attendus pour le quatri\u00e8me trimestre 2022<\/h4>\n<p>L&rsquo;\u00e9tude vise \u00e0 approfondir les r\u00e9sultats pr\u00e9c\u00e9demment publi\u00e9s d\u00e9montrant une r\u00e9duction de la d\u00e9ficience motrice avec les inhibiteurs de l&rsquo;OGA d&rsquo;Asceneuron dans ce mod\u00e8le de maladie g\u00e9n\u00e9tique. Le projet d\u00e9butera imm\u00e9diatement et les r\u00e9sultats sont attendus pour le quatri\u00e8me trimestre de 2022.<\/p>\n<p>Dirk Beher, CEO et co-fondateur d&rsquo;Asceneuron, a d\u00e9clar\u00e9 : \u00ab\u00a0Nous sommes ravis d&rsquo;avoir obtenu un soutien financier suppl\u00e9mentaire de la part de la Fondation Michael J. Fox pour faire progresser la recherche sur notre inhibiteur de O-GlcNAcase de nouvelle g\u00e9n\u00e9ration, l&rsquo;ASN51. L&rsquo;ASN51 a le potentiel d&rsquo;avoir un impact significatif sur les patients souffrant de la maladie de Parkinson afin d&rsquo;am\u00e9liorer leur qualit\u00e9 de vie et de ralentir la maladie. Nous sommes fiers de recevoir le soutien continu d&rsquo;une fondation qui contribue de mani\u00e8re concr\u00e8te au d\u00e9veloppement de th\u00e9rapies plus efficaces pour les personnes atteintes de la maladie de Parkinson.\u00a0\u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00e9termin\u00e9e \u00e0 acc\u00e9l\u00e9rer la recherche de nouvelles th\u00e9rapies pour la maladie de Parkinson, la Michael J. Fox Foundation for Parkinson&rsquo;s Research octroie une deuxi\u00e8me bourse \u00e0 Asceneuron pour faire avancer l&rsquo;\u00e9tude de son m\u00e9dicament candidat en phase clinique comme nouveau traitement potentiel.<\/p>\n","protected":false},"author":3,"featured_media":10634,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1041,1069],"class_list":["post-10633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-financing-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"D\u00e9termin\u00e9e \u00e0 acc\u00e9l\u00e9rer la recherche de nouvelles th\u00e9rapies pour la maladie de Parkinson, la Michael J. Fox Foundation for Parkinson&#039;s Research octroie une deuxi\u00e8me bourse \u00e0 Asceneuron pour faire avancer l&#039;\u00e9tude de son m\u00e9dicament candidat en phase clinique comme nouveau traitement potentiel.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-10T04:48:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson\",\"datePublished\":\"2022-05-10T04:48:03+00:00\",\"dateModified\":\"2023-07-04T11:43:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg\",\"keywords\":[\"Biotech\",\"Financing\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\",\"name\":\"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg\",\"datePublished\":\"2022-05-10T04:48:03+00:00\",\"dateModified\":\"2023-07-04T11:43:55+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/","og_locale":"fr_FR","og_type":"article","og_title":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area","og_description":"D\u00e9termin\u00e9e \u00e0 acc\u00e9l\u00e9rer la recherche de nouvelles th\u00e9rapies pour la maladie de Parkinson, la Michael J. Fox Foundation for Parkinson's Research octroie une deuxi\u00e8me bourse \u00e0 Asceneuron pour faire avancer l'\u00e9tude de son m\u00e9dicament candidat en phase clinique comme nouveau traitement potentiel.","og_url":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-05-10T04:48:03+00:00","article_modified_time":"2023-07-04T11:43:55+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson","datePublished":"2022-05-10T04:48:03+00:00","dateModified":"2023-07-04T11:43:55+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/"},"wordCount":386,"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg","keywords":["Biotech","Financing","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/","url":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/","name":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg","datePublished":"2022-05-10T04:48:03+00:00","dateModified":"2023-07-04T11:43:55+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Parkinsons-disease-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/la-fondation-michael-j-fox-accorde-une-bourse-a-asceneuron-pour-traiter-la-maladie-de-parkinson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"La Fondation Michael J. Fox accorde une bourse \u00e0 Asceneuron pour traiter la maladie de Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=10633"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10633\/revisions"}],"predecessor-version":[{"id":18142,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10633\/revisions\/18142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/10634"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=10633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=10633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=10633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}